The FDA has declined to approve Vanda Pharma's tradipitant for delayed gastric emptying (gastroparesis), prompting a furious response from the company. In a statement, the company says the FDA's ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Quietus of the Knights came out of nowhere to receive critical acclaim just a few years ago. Last year, a sequel was ...

After hours: January 28 at 4:03:10 PM EST Loading Chart for VNDA ...

Here’s how it works. COCOA BEACH, Florida — Blue Origin's New Glenn rocket just earned its wings. New Glenn launched for the first time ever this morning (Jan. 16), rising off a pad at ...

On a Florida launchpad that has been dormant for almost two decades, a new, roughly 320-foot (98-meter) rocket — developed by Jeff Bezos’ company Blue Origin — is poised for its maiden flight.

VHX-896 is under clinical development by Vanda Pharmaceuticals and currently in Phase III for Schizophrenia. According to GlobalData, Phase III drugs for Schizophrenia have a 68% phase transition ...

Earth won't experience another Blue Moon until 2026. Here we explore this phenomenon in more detail. When you purchase through links on our site, we may earn an affiliate commission. Here’s how ...

Learn more› By Kaitlyn Wells and Zoe Vanderweide If you believe the hype, blue-light blocking glasses will prevent headaches, decrease eyestrain, and help you sleep like a baby. But do they work?